NovoCure Ltd Quarterly Common Stock, Shares, Issued from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
NovoCure Ltd quarterly Common Stock, Shares, Issued history and growth rate from Q4 2014 to Q3 2024.
  • NovoCure Ltd Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 108M shares, a 1.27% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 108M +1.35M +1.27% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 108M +1.41M +1.32% Jun 30, 2024 10-Q 2024-07-25
Q1 2024 108M +1.42M +1.33% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 107M +2.03M +1.93% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 107M +1.81M +1.72% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 107M +1.88M +1.79% Jun 30, 2023 10-Q 2023-07-27
Q1 2023 106M +1.63M +1.56% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 105M +1.08M +1.04% Dec 31, 2022 10-K 2024-02-22
Q3 2022 105M +1.13M +1.08% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 105M +1.09M +1.05% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 105M +1.37M +1.33% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 104M +1.64M +1.6% Dec 31, 2021 10-K 2023-02-23
Q3 2021 104M +2.09M +2.05% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 104M +2.62M +2.59% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 103M +2.82M +2.81% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 102M +2.81M +2.82% Dec 31, 2020 10-K 2022-02-24
Q3 2020 102M +2.78M +2.81% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 101M +3.16M +3.23% Jun 30, 2020 10-Q/A 2020-10-02
Q1 2020 100M +4.67M +4.88% Mar 31, 2020 10-Q/A 2020-10-02
Q4 2019 99.5M +6.27M +6.73% Dec 31, 2019 10-K 2021-02-25
Q3 2019 98.9M +5.94M +6.39% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 97.9M +5.36M +5.79% Jun 30, 2019 10-Q 2019-07-25
Q1 2019 95.7M +5.29M +5.86% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 93.3M +3.78M +4.22% Dec 31, 2018 10-K 2020-02-27
Q3 2018 93M +3.65M +4.09% Sep 30, 2018 10-Q 2018-10-25
Q2 2018 92.5M +3.87M +4.37% Jun 30, 2018 10-Q 2018-07-26
Q1 2018 90.4M +2.27M +2.57% Mar 31, 2018 10-Q 2018-04-26
Q4 2017 89.5M +2.41M +2.77% Dec 31, 2017 10-K 2019-02-28
Q3 2017 89.4M +3.58M +4.17% Sep 30, 2017 10-Q 2017-10-26
Q2 2017 88.6M +2.86M +3.33% Jun 30, 2017 10-Q 2017-07-27
Q1 2017 88.1M +3.71M +4.39% Mar 31, 2017 10-Q 2017-04-27
Q4 2016 87.1M +3.29M +3.92% Dec 31, 2016 10-K 2018-02-22
Q3 2016 85.8M +73.3M +590% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 85.8M Jun 30, 2016 10-Q 2016-07-28
Q1 2016 84.4M Mar 31, 2016 10-Q 2016-05-10
Q4 2015 83.8M +70.3M +524% Dec 31, 2015 10-K 2017-02-23
Q3 2015 12.4M Sep 30, 2015 10-Q 2015-10-27
Q4 2014 13.4M Dec 31, 2014 10-K 2016-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.